Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,911 | 115 | 93.6% |
| Education | $198.00 | 2 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $473.79 | 11 | $0 (2024) |
| PFIZER INC. | $406.10 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $377.31 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $276.45 | 14 | $0 (2024) |
| Incyte Corporation | $234.36 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $209.77 | 8 | $0 (2024) |
| ABBVIE INC. | $178.75 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $176.31 | 8 | $0 (2024) |
| Lilly USA, LLC | $100.84 | 6 | $0 (2024) |
| Celgene Corporation | $87.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,589 | 59 | PFIZER INC. ($336.55) |
| 2023 | $1,464 | 56 | AstraZeneca Pharmaceuticals LP ($320.07) |
| 2022 | $56.63 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($33.46) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Oncology | ||||||
| 12/12/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Oncology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.96 | General |
| 11/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Oncology | ||||||
| 11/14/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), DARZALEX | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| 11/11/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.81 | General |
| Category: Hematology/Oncology | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 10/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Oncology | ||||||
| 10/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.33 | General |
About Dalgis Durand
Dalgis Durand is a Nurse Practitioner healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2021. The National Provider Identifier (NPI) number assigned to this provider is 1760073175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dalgis Durand has received a total of $3,109 in payments from pharmaceutical and medical device companies, with $1,589 received in 2024. These payments were reported across 117 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,911).
Practice Information
- Specialty Nurse Practitioner
- Location Hialeah, FL
- Active Since 01/28/2021
- Last Updated 01/28/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760073175
Products in Payments
- IMFINZI (Biological) $273.70
- IMBRUVICA (Drug) $203.50
- VENCLEXTA (Drug) $162.86
- INLYTA (Drug) $152.62
- XTANDI (Drug) $152.55
- JAKAFI (Drug) $135.36
- NINLARO (Drug) $129.12
- KEYTRUDA (Biological) $128.48
- TAGRISSO (Drug) $124.99
- PLUVICTO (Drug) $110.59
- BOSULIF (Drug) $100.93
- TECVAYLI (Biological) $93.97
- Pomalyst (Drug) $87.09
- SANCUSO (Drug) $75.25
- Tibsovo (Drug) $71.08
- LUTATHERA (Drug) $69.11
- KISQALI (Drug) $65.85
- VERZENIO (Drug) $64.49
- Lenvima (Drug) $57.90
- Stivarga (Drug) $53.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Hialeah
Domingo Luis, Arnp, ARNP
Nurse Practitioner — Payments: $4,615
Hibelis Patton, Arnp, ARNP
Nurse Practitioner — Payments: $4,483
Cristina Rivero, Aprn, APRN
Nurse Practitioner — Payments: $3,072
Heidy Dorta, Arnp, ARNP
Nurse Practitioner — Payments: $1,970
Orbein Mallet-Varela, Aprn, APRN
Nurse Practitioner — Payments: $1,497
Jose Guerrero, Fnp, FNP
Nurse Practitioner — Payments: $1,493